Square Pharmaceuticals PLC SQURPHARMA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 9.38
- Price/Sales
- 2.67
- Dividend Yield (Trailing)
- 5.05%
- Dividend Yield (Forward)
- 5.05%
- Total Yield
- 5.01%
Company Profile
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. The company operates in Bangladesh and sells its products locally and internationally. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 12,503
- Website
- http://www.squarepharma.com.bd
Comparables
Valuation
|
Metric
|
SQURPHARMA
|
543748
|
4577
|
|---|---|---|---|
Price/Earnings (Normalized) | 9.38 | 26.06 | 12.11 |
Price/Book Value | 1.51 | 3.17 | 0.71 |
Price/Sales | 2.67 | 3.00 | 0.82 |
Price/Cash Flow | 12.02 | 17.34 | 5.83 |
Price/Earnings
SQURPHARMA
543748
4577
Financial Strength
|
Metric
|
SQURPHARMA
|
543748
|
4577
|
|---|---|---|---|
Quick Ratio | 3.70 | 0.90 | 0.82 |
Current Ratio | 4.68 | 1.94 | 2.29 |
Interest Coverage | 101.31 | 18.46 | 197.65 |
Quick Ratio
SQURPHARMA
543748
4577
Profitability
|
Metric
|
SQURPHARMA
|
543748
|
4577
|
|---|---|---|---|
Return on Assets (Normalized) | 16.00% | 9.32% | 5.80% |
Return on Equity (Normalized) | 17.28% | 13.35% | 8.27% |
Return on Invested Capital (Normalized) | 14.24% | 12.33% | 7.32% |
Return on Assets
SQURPHARMA
543748
4577
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Zxkpplysz | Cnvwzn | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Qmnpcmbrt | Sgzd | $79.3 Bil | |
HLN
| Haleon PLC ADR | Vbndfqb | Qxrr | $38.1 Bil | |
VTRS
| Viatris Inc | Drzdffmk | Pjtc | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Dbdqxgxz | Pkrj | $11.7 Bil | |
CTLT
| Catalent Inc | Lytbshgb | Tqnys | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Sccwsxmdb | Djltj | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Hbktldsyw | Skx | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wftdpfmn | Wzdnl | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Hpppbprcx | Xkbf | $3.1 Bil |